Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
Shasqi, Inc.
Shasqi, Inc.
Actym Therapeutics, Inc.
Elevation Oncology
Pfizer
Hoffmann-La Roche
Tocagen Inc.
University of Wisconsin, Madison
CureOne
University Health Network, Toronto
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center